Cipla Methotrexate 2.5mg (Imutrex) 100 Tablets

Cipla Methotrexate 2.5mg (Imutrex) 100 Tablets Cipla Methotrexate 2.5mg is a specialized medication classified as a Disease-Modifying Antirheumatic Drug (DMARD) and an antimetabolite. It is widely used in Nigeria for the management of chronic conditions such as Rheumatoid Arthritis, Severe Psoriasis, and certain types of neoplastic diseases like Leukemia. How Cipla Methotrexate Works The active ingredient, Methotrexate, works by inhibiting the enzyme dihydrofolate reductase. This action slows down the production of DNA and cell replication, which is effective in reducing the overactive immune response in autoimmune diseases and slowing the growth of cancer cells. Indications and Usage This medication is primarily indicated for:

Rheumatoid Arthritis: To reduce joint pain, swelling, and long-term damage. Psoriasis: For severe, resistant cases that do not respond to other treatments. Oncology: As part of maintenance therapy for Acute Lymphoblastic Leukemia (ALL).

Important Dosage Warning Note: For most conditions like Rheumatoid Arthritis and Psoriasis, Cipla Methotrexate is taken as a WEEKLY dose, not a daily dose. Taking this medication daily by mistake can lead to fatal toxicity. Always follow the specific instructions provided by your doctor or Meddylab pharmacist. Side Effects and Safety Methotrexate is a potent medication. Common side effects may include nausea, fatigue, and mouth ulcers. Because it can affect liver function and bone marrow, regular blood tests are necessary during treatment. Consult with a healthcare professional or contact a Meddylab pharmacist if you experience persistent symptoms.

Product identification: Cipla Methotrexate 2.5mg (Imutrex) 100 Tablets is listed under Cancer. Use the exact product name when comparing alternatives or discussing an order with the supplier.